Harry Kleanthous
Corporate Officer/Principal at SK BIOSCIENCE CO.,LTD.
Profile
Harry Kleanthous is currently working as Vice President-Research at Acambis Plc and EVP-Vaccine Research & Development Strategy at SK bioscience Co., Ltd.
He holds a doctorate degree from the University of London.
Harry Kleanthous active positions
| Companies | Position | Start |
|---|---|---|
| SK BIOSCIENCE CO.,LTD. | Corporate Officer/Principal | 2022-10-20 |
Acambis Plc
 Acambis Plc BiotechnologyHealth Technology Acambis Plc develops biopharmaceutical products and vaccines. It offers ACAM2000, a smallpox vaccine for emergency-use stockpiling; and ChimeriVax-JE, a single-dose Japanese encephalitis vaccine for endemic markets and travelers. Its products in pipeline include ChimeriVax-JE, ChimeriVax-West Nile, and ChimeriVax-Dengue. The company was founded in 1992 and is headquartered in Cambridge, UK. | Corporate Officer/Principal | - |
Training of Harry Kleanthous
| University of London | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| SK BIOSCIENCE CO.,LTD. | Health Technology |
| Private companies | 1 |
|---|---|
Acambis Plc
Acambis Plc BiotechnologyHealth Technology Acambis Plc develops biopharmaceutical products and vaccines. It offers ACAM2000, a smallpox vaccine for emergency-use stockpiling; and ChimeriVax-JE, a single-dose Japanese encephalitis vaccine for endemic markets and travelers. Its products in pipeline include ChimeriVax-JE, ChimeriVax-West Nile, and ChimeriVax-Dengue. The company was founded in 1992 and is headquartered in Cambridge, UK. | Health Technology |
- Stock Market
- Insiders
- Harry Kleanthous